DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.902
EU - Europa 7.306
AS - Asia 4.487
OC - Oceania 41
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 10
Totale 35.799
Nazione #
US - Stati Uniti d'America 23.864
CN - Cina 2.289
DE - Germania 1.993
UA - Ucraina 1.575
IT - Italia 1.425
TR - Turchia 982
SG - Singapore 862
GB - Regno Unito 669
FI - Finlandia 388
SE - Svezia 358
RU - Federazione Russa 338
PL - Polonia 242
ID - Indonesia 148
FR - Francia 88
BE - Belgio 59
VN - Vietnam 57
HK - Hong Kong 48
AU - Australia 35
CA - Canada 31
CZ - Repubblica Ceca 27
RO - Romania 24
BR - Brasile 23
IE - Irlanda 20
IR - Iran 20
IN - India 19
JP - Giappone 19
NL - Olanda 17
CH - Svizzera 16
ES - Italia 16
DK - Danimarca 11
EU - Europa 11
KR - Corea 9
IL - Israele 8
GR - Grecia 7
MX - Messico 7
IQ - Iraq 6
NZ - Nuova Zelanda 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
EG - Egitto 5
AR - Argentina 4
AT - Austria 4
BG - Bulgaria 4
EC - Ecuador 4
LU - Lussemburgo 4
MD - Moldavia 4
AM - Armenia 3
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
PT - Portogallo 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
LT - Lituania 2
SA - Arabia Saudita 2
TH - Thailandia 2
BN - Brunei Darussalam 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
LI - Liechtenstein 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 35.799
Città #
Fairfield 3.221
Woodbridge 3.031
Houston 2.106
Jacksonville 1.824
Chandler 1.735
Ann Arbor 1.603
Ashburn 1.424
Wilmington 1.201
Seattle 1.150
Cambridge 941
Izmir 684
Singapore 624
Nanjing 532
Ferrara 506
Princeton 441
Beijing 366
Boardman 300
San Diego 289
Warsaw 225
Addison 209
Shanghai 202
Nanchang 150
Jakarta 147
New York 147
Shenyang 146
Milan 143
Dearborn 134
Bremen 115
Hebei 107
Los Angeles 107
Tianjin 99
Jiaxing 96
Redwood City 86
Santa Clara 84
Changsha 75
Mountain View 68
Norwalk 67
Munich 60
Falls Church 57
Brussels 56
Dong Ket 56
Zhengzhou 53
Jinan 50
San Mateo 48
London 46
Helsinki 42
Kunming 42
Ningbo 39
Guangzhou 37
Hong Kong 36
Orange 35
Rome 35
Auburn Hills 32
Des Moines 30
Indiana 30
Chicago 28
Tappahannock 27
Augusta 26
Bologna 25
Washington 25
Taizhou 24
Hangzhou 23
Padova 23
Verona 22
Catania 21
Brno 20
Philadelphia 20
Redmond 18
Lanzhou 16
Monmouth Junction 16
Haikou 15
Kilburn 13
Lappeenranta 13
Leawood 13
Rovereto 12
Montréal 10
San Francisco 10
Changchun 9
Copenhagen 9
Ferrara di Monte Baldo 9
Palermo 9
Ardabil 8
Hefei 8
Napoli 8
Pescara 8
Walnut 8
Dublin 7
Hounslow 7
Ottawa 7
Trento 7
Vicenza 7
Acton 6
Berkeley 6
Calvisano 6
Chiswick 6
Frankfurt am Main 6
Fuzhou 6
Menlo Park 6
Saint Albans 6
Salerno 6
Totale 25.754
Nome #
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 314
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 243
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 200
IL PROCESSO INFIAMMATORIO 196
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 177
P2X7 targeting inhibits growth of human mesothelioma 175
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. 169
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 161
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 158
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 156
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 155
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 151
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP 149
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 148
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 146
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 146
Purinergic signaling in the immune system 143
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 140
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 140
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 140
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 139
Role of P2X7 receptor in host response to melanoma 139
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 137
Extracellular purines, purinergic receptors and tumor growth 136
The antibiotic polymyxin B modulates P2X7 receptor function 133
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 133
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 132
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 132
The P2X7 receptor is a key modulator of aerobic glycolysis. 132
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis 132
Expression of P2X7 receptor increases in vivo tumor growth 131
The P2X7 receptor-interleukin-1 liaison 130
The P2X7 receptor: a key player in IL-1 processing and release 129
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 129
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 128
Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase 127
The antibiotic polymyxin B modulates P2X7 receptor function 127
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 127
Purinoceptor function in the immune system 126
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 125
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 124
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity 124
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors 124
P2 receptors in cancer progression and metastatic spreading 124
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 123
ATP-mediated cytotoxicity in microglial cells 121
Insight on P2X7 receptor role as oncogene 120
The P2X7 Receptor in Infection and Inflammation 120
Extracellular nucleotides and nucleosides as signalling molecules 120
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 118
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 118
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 118
Purinergic regulation of airway inflammation 118
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 118
Activation of muscarinic receptors in PC12 cells. Correlation between cytosolic Ca2+ rise and phosphoinositide hydrolysis. 117
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 117
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 116
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 116
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 115
null 115
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 115
The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner 114
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 113
Role of the P2X7 receptor in tumor-associated inflammation 113
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 112
Acute myeloid leukaemia:analysis of the expression of P2X7a and P2X7B isoforms 112
null 111
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 111
null 111
Sidedness of e− Donation and Stoichiometry of H+ Pumps at Sites II + III in Mitochondria from Rat Liver 111
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells 110
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 110
Activation of muscarinic receptors in PC12 cells. Stimulation of Ca2+ influx and redistribution. 110
P2 purinoceptors in the immune system 110
The P2X7 receptor : from ion channel to oncogene 110
Dysfunctional inflammasome in Schnitzler's syndrome 110
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 110
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor containing a tyrosine moiety 109
Cell-mediated cytotoxicity: ATP as an effector and the role of target cells 109
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 109
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 109
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease 109
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 109
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. 108
Liaisons dangereuses: P2X7 and the inflammasome 107
Intracellular signalling in Te85 osteosarcoma cells expressing P2X7R isoforms A and B 107
H+/site, charge/site, and ATP/site ratios in mitochondrial electron transport. 107
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 107
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 106
The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release 106
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production 106
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes 106
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. 106
Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. 106
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 106
Inhibitory effect of P2X7 receptor antagonists on in vivo tumor growth 105
ATP receptors and giant cell formation 105
intracellular calcium handling by fibroblasts from non insulin dependent diabetic patients with and without hypertension and microalbuminuria 105
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 105
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 105
Totale 12.767
Categoria #
all - tutte 164.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.804
Totale 168.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.688 0 0 0 1.083 503 907 653 776 612 673 311 170
2020/20215.249 457 432 230 571 286 530 223 597 202 659 703 359
2021/20224.501 123 468 260 157 278 213 237 250 197 356 434 1.528
2022/20234.150 486 173 139 487 685 598 123 447 540 53 280 139
2023/20242.128 235 314 91 62 189 262 91 145 47 49 93 550
2024/20251.276 266 278 720 12 0 0 0 0 0 0 0 0
Totale 36.474